HomeMNPR • NASDAQ
add
Monopar Therapeutics Inc
Previous close
$31.87
Day range
$32.62 - $34.98
Year range
$1.72 - $54.10
Market cap
213.27M USD
Avg Volume
31.29K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.07M | 479.22% |
Net income | -10.93M | -502.32% |
Net profit margin | — | — |
Earnings per share | -2.75 | -358.33% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 60.21M | 728.68% |
Total assets | 60.29M | 720.83% |
Total liabilities | 5.25M | 198.98% |
Total equity | 55.04M | — |
Shares outstanding | 6.11M | — |
Price to book | 3.53 | — |
Return on assets | -83.44% | — |
Return on capital | -92.31% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -10.93M | -502.32% |
Cash from operations | -2.00M | -29.27% |
Cash from investing | -14.34M | -582.70% |
Cash from financing | 56.14M | 16,679.90% |
Net change in cash | 39.80M | 2,173.12% |
Free cash flow | -2.54M | -170.76% |
About
Founded
2014
Headquarters
Website
Employees
16
